Fund Holdings — Casdin Capital, LLC

Total Portfolio Value:
$1.32B
Total Bought:
$154.03M
Total Sold:
$186.66M
Net Transaction:
-$32.63M
Notable People:
Eli D Casdin, Lawrence Jude Canzoneri, Alexandria Fisk, Angelo Crupi, Steven Michael Giordano
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Revolution Medicines, Inc.(RVMD)2,577,3332,577,3330$205.28M$250.65M18.98%+$45.36M
GeneDx Holdings Corp.CL A(WGS)3,007,1643,007,1640$391.11M$193.12M14.62%-$197.99M
Relay Therapeutics, Inc.(RLAY)13,003,57414,418,574+1,415,000$110.01M$143.46M10.86%+$33.45M
Biolife Solutions Inc5,957,1655,957,1650$144.04M$113.66M8.61%-$30.38M
Standard BioTools Inc.(LAB)88,783,85688,783,8560$113.64M$81.62M6.18%-$32.02M
Illumina, Inc.(ILMN)600,000530,000-70,000$78.70M$65.33M4.95%-$13.37M
Structure Therapeutics IncADS1,175,0001,175,0000$81.72M$56.63M4.29%-$25.09M
10x Genomics, Inc.CL A(TXG)1,400,0002,275,000+875,000$22.83M$48.30M3.66%+$25.46M
Denali Therapeutics Inc.(DNLI)1,840,0001,840,0000$30.38M$35.33M2.68%+$4.95M
Beam Therapeutics Inc.(BEAM)1,600,0001,350,000-250,000$44.35M$32.17M2.44%-$12.18M
Guardant Health, Inc.(GH)380,000315,000-65,000$38.81M$29.10M2.20%-$9.72M
Neurogene Inc.(NGNE)1,295,3611,420,361+125,000$26.68M$28.63M2.17%+$1.95M
Alnylam Pharmaceuticals, Inc.(ALNY)75,00075,0000$29.82M$24.82M1.88%-$5.01M
Maze Therapeutics, Inc.(MAZE)758,857758,8570$31.44M$22.65M1.72%-$8.79M
Scholar Rock Holding Corporation(SRRK)260,000350,000+90,000$11.45M$17.21M1.30%+$5.75M
AgomAb Therapeutics NVADS(AGMB)01,550,000+1,550,000$0$16.26M1.23%+$16.26M
Hims & Hers Health, Inc.CL A(HIMS)385,000700,000+315,000$12.50M$14.53M1.10%+$2.03M
Taysha Gene Therapies, Inc.(TSHA)1,500,0003,250,000+1,750,000$8.25M$14.53M1.10%+$6.28M
Qiagen N.V.(QGEN)0360,000+360,000$0$14.41M1.09%+$14.41M
Tempus AI, Inc.CL A(TEM)294,127294,1270$17.37M$13.30M1.01%-$4.07M
Septerna, Inc.(SEPN)553,268553,2680$15.43M$13.30M1.01%-$2.13M
GRAIL, Inc.(GRAL)0230,000+230,000$0$11.89M0.90%+$11.89M
Prime Medicine, Inc.(PRME)3,167,1753,167,1750$10.99M$11.02M0.83%+$31.7K
Personalis, Inc.(PSNL)01,600,000+1,600,000$0$10.19M0.77%+$10.19M
Quest Diagnostics Incorporated(DGX)50,00050,0000$8.68M$9.80M0.74%+$1.12M
Veracyte, Inc.(VCYT)276,308276,3080$11.63M$8.90M0.67%-$2.73M
MoonLake ImmunotherapeuticsCL A(MLTX)0450,000+450,000$0$8.39M0.64%+$8.39M
Intellia Therapeutics, Inc.(NTLA)0355,000+355,000$0$4.55M0.34%+$4.55M
Disc Medicine, Inc.(IRON)065,000+65,000$0$4.16M0.31%+$4.16M
Moderna, Inc.(MRNA)075,000+75,000$0$3.81M0.29%+$3.81M
Adlai Nortye Group Ltd.ADS(ANL)0538,461+538,461$0$3.73M0.28%+$3.73M
Monte Rosa Therapeutics, Inc.(GLUE)86,014186,014+100,000$1.35M$3.06M0.23%+$1.71M
Absci Corporation973,260973,2600$3.40M$2.92M0.22%-$476.9K
Century Therapeutics, Inc.(IPSC)1,228,1901,228,1900$1.22M$2.78M0.21%+$1.55M
BridgeBio Oncology Therapeutics, Inc.(BBOT)282,312282,3120$3.53M$2.53M0.19%-$1.01M
Contineum Therapeutics, Inc.CL A(CTNM)148,333148,3330$1.70M$1.94M0.15%+$241.8K
Pacific Biosciences of California, Inc.(PACB)4,223,767723,767-3,500,000$7.90M$955.4K0.07%-$6.94M
Recursion Pharmaceuticals, Inc.CL A(RXRX)165,323165,3230$676.2K$507.5K0.04%-$168.6K
Tenaya Therapeutics, Inc.(TNYA)361,969361,9690$257.5K$250.6K0.02%-$6.9K
Ginkgo Bioworks Holdings, Inc.CL A(DNA)36,49336,4930$303.3K$223.7K0.02%-$79.6K
ARS Pharmaceuticals, Inc.(SPRY)1,600,0000-1,600,000$18.64M$0—-$18.64M
Avidity Biosciences Inc1,000,0000-1,000,000$72.13M$0—-$72.13M
DexCom, Inc.(DXCM)175,0000-175,000$11.61M$0—-$11.61M
Incyte Corporation(INCY)100,0000-100,000$9.88M$0—-$9.88M
Legend Biotech CorporationADS(LEGN)215,0000-215,000$4.67M$0—-$4.67M
The Cigna Group(CI)40,0000-40,000$11.01M$0—-$11.01M
UnitedHealth Group Incorporated(UNH)50,0000-50,000$16.51M$0—-$16.51M
Page 1 of 1